DocGo Inc. (NASDAQ:DCGO – Get Free Report) has received an average recommendation of “Hold” from the six analysts that are covering the stock, Marketbeat.com reports. One investment analyst has rated the stock with a sell rating, two have assigned a hold rating and three have given a buy rating to the company. The average 12 month price target among analysts that have covered the stock in the last year is $2.3750.
A number of research firms have recently weighed in on DCGO. Wall Street Zen raised shares of DocGo from a “sell” rating to a “hold” rating in a research note on Saturday, May 16th. Weiss Ratings reiterated a “sell (e+)” rating on shares of DocGo in a research note on Thursday, June 18th. Finally, Cantor Fitzgerald reissued an “overweight” rating on shares of DocGo in a report on Monday, May 11th.
Get Our Latest Report on DocGo
DocGo Price Performance
DocGo (NASDAQ:DCGO – Get Free Report) last released its quarterly earnings data on Monday, May 11th. The company reported ($0.12) earnings per share (EPS) for the quarter, missing the consensus estimate of ($0.02) by ($0.10). The business had revenue of $75.55 million during the quarter, compared to analysts’ expectations of $72.48 million. DocGo had a negative return on equity of 44.09% and a negative net margin of 62.23%. Research analysts anticipate that DocGo will post -0.12 EPS for the current year.
Institutional Investors Weigh In On DocGo
Institutional investors have recently modified their holdings of the company. Ieq Capital LLC acquired a new stake in shares of DocGo in the 2nd quarter worth approximately $126,000. Diversify Advisory Services LLC purchased a new position in DocGo in the 2nd quarter valued at approximately $53,000. BlackRock Inc. acquired a new position in DocGo during the second quarter worth $750,000. GSA Capital Partners LLP acquired a new position in DocGo during the second quarter worth $517,000. Finally, Marquette Asset Management LLC purchased a new stake in DocGo during the second quarter worth $175,000. Hedge funds and other institutional investors own 56.44% of the company’s stock.
DocGo Company Profile
DocGo, Inc is a U.S.-based integrated healthcare company that delivers on-demand and mobile healthcare services. The company’s business model centers on deploying customized medical clinics paired with a digital care platform to bring primary and acute care directly to patients. Through a combination of telemedicine and over-the-road medical units, DocGo addresses routine medical exams, chronic disease management, occupational health screenings, specialist consultations and urgent care interventions.
In addition to its mobile clinic fleet, DocGo’s digital platform offers 24/7 virtual care, facilitating remote consultations via video, phone or secure messaging.
Featured Stories
- Five stocks we like better than DocGo
- Asian Market Circuit Breakers Hit Stocks, Not AI Demand
- Riot Platforms Re-Wires the Ledger for a $9B AI Power Play
- Nebius Just Exploded 34% on Blowout Earnings—Is It Time to Buy?
- Joby’s Defense Pivot Accelerates With $500M Resonant Sciences Deal
Receive News & Ratings for DocGo Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for DocGo and related companies with MarketBeat.com's FREE daily email newsletter.
